Inventor · disambiguated record
Michael Higginbottom
Also filed as: HIGGINBOTTOM MICHAEL
18 granted patents·18 pending applications·32 citations·filing 1999–2021
92Inventor score
Files withPROXIMAGEN LTD5BENEVOLENTAI CAMBRIDGE LTD4CHAPMAN EMMA3PROXIMAGEN LLC3ASTRAZENECA AB PUBL2
Top patents by PatentIndex Score
36 records- 0188US10995091B2CXCR4 receptor antagonistsPROXIMAGEN LLC·Filed 2018·Granted May 4, 2021·3 cites·14 claims
- 0285US10155761B2CXCR4 receptor antagonistsPROXIMAGEN LLC·Filed 2017·Granted Dec 18, 2018·4 cites·16 claims
- 0383US9353086B2CXCR4 receptor antagonistsSAVORY EDWARD DANIEL·Filed 2011·Granted May 31, 2016·6 cites·17 claims
- 0483US8263616B24,5,6,7-tetrahydroimidazo[4,5-c]pyridine compoundsSAVORY EDWARD DANIEL·Filed 2009·Granted Sep 11, 2012·5 cites·7 claims
- 0580US9493457B24,5,6,7-tetrahyroimidazo[4,5-c]pyridine compoundsPROXIMAGEN LTD·Filed 2015·Granted Nov 15, 2016·2 cites·8 claims
- 0676US9890160B2Compounds IPROXIMAGEN LTD·Filed 2016·Granted Feb 13, 2018·1 cites·16 claims
- 0775US7807685B2Therapeutic compoundsCBT DEV LTD·Filed 2007·Granted Oct 5, 2010·4 cites·5 claims
- 0873US9035066B2Method of using 4,5,6,7-tetrahydroimidazo[4,5-C]pyridine compoundsPROXIMAGEN LTD·Filed 2013·Granted May 19, 2015·1 cites·20 claims
- 0972US8569338B2Methods of using 4, 5, 6, 7-tetrahydroimidazo-[4,5-c]pyridine compoundsSAVORY EDWARD·Filed 2012·Granted Oct 29, 2013·2 cites·15 claims
- 1072US2022348577A1CXCR4 Receptor AntagonistsPROXIMAGEN LLC·Filed 2021·Application pending·0 cites
- 1167US11040969B2Compounds IBENEVOLENTAI CAMBRIDGE LTD·Filed 2019·Granted Jun 22, 2021·0 cites·6 claims
- 1267US7851471B2Compounds IASTRAZENECA AB PUBL·Filed 2008·Granted Dec 14, 2010·2 cites·20 claims
- 1366US9150574B2Enzyme inhibitor compoundsEVANS DAVID·Filed 2011·Granted Oct 6, 2015·1 cites·12 claims
- 1465US9227967B2Inhibitor compounds of semicarbazide-sensitive amine oxidasesEVANS DAVID·Filed 2011·Granted Jan 5, 2016·1 cites·37 claims
- 1563US10399973B2Compounds IBENEVOLENTAI CAMBRIDGE LTD·Filed 2017·Granted Sep 3, 2019·0 cites·12 claims
- 1653US2016046606A1CXCR4 Receptor AntagonistsPROXIMAGEN LTD·Filed 2015·Application pending·0 cites
- 1750US10988473B2Process for the preparation of (3S,4S)-tetrahydrofuran-3-yl 4-isopropyl-6,7-dihydro-3H-imidazo[4,5-C]pyridine-5(4H)-carboxylateBENEVOLENTAI CAMBRIDGE LTD·Filed 2017·Granted Apr 27, 2021·0 cites·20 claims
- 1850US2011275678A1New Pyridine Derivatives as Leptin Receptor Modulator MimeticsHIGGINBOTTOM MICHAEL·Filed 2009·Application pending·0 cites
- 1948US2016318891A1Tonabersat prodrugsPROXIMAGEN LTD·Filed 2014·Application pending·0 cites
- 2047US2009176798A1New compounds IIIBIOVITRUM AB·Filed 2008·Application pending·0 cites
- 2145US2003065007A1NK1 receptor antagonistsFiled 2002·Application pending·0 cites
- 2244US2009203695A1Compounds IVBIOVITRUM AB·Filed 2008·Application pending·0 cites
- 2344US2011275638A1Piperazine derivatives and their use as leptin receptor modulatorsCHAPMAN EMMA·Filed 2009·Application pending·0 cites
- 2444US2011275670A1New Compounds VIICHAPMAN EMMA·Filed 2009·Application pending·0 cites
- 2543US10316034B2Pharmaceutical salt forms of an inhibitor of semicarbazide-sensitive amine oxidase (SSAO)BENEVOLENTAI CAMBRIDGE LTD·Filed 2016·Granted Jun 11, 2019·0 cites·8 claims
- 2642US2004063643A1Bombesin antagonistsPFIZER·Filed 2003·Application pending·0 cites
- 2742US2002169101A1Treatment of sexual dysfunctionFiled 2001·Application pending·0 cites
- 2841US2011275637A1Piperazine derivatives and their use as leptin receptor modulatorsCHAPMAN EMMA·Filed 2009·Application pending·0 cites
- 2939US2004116440A1Bombesin receptor antagonistsFiled 2001·Application pending·0 cites
- 3039US2004110768A1Bombesin receptor antagonistsFiled 2001·Application pending·0 cites
- 3136US8093248B2Compounds useful for the treatment of conditions associated with weight gainBOYD JOSEPH W·Filed 2008·Granted Jan 10, 2012·0 cites·17 claims
- 3235US2011046135A1New compounds iASTRAZENECA AB PUBL·Filed 2010·Application pending·0 cites
- 3334US2004087561A1Treatment of sexual dysfunctionFiled 2001·Application pending·0 cites
- 3433US2013324556A1Protease Activated Receptor 2 (PAR2) AntagonistsBOYD JOE WILLIAM·Filed 2012·Application pending·0 cites
- 3533US2013252951A17-hydroxy-pyrazolo[1,5-a] pyrimidine compounds and their use as ccr2 receptor antagonistsBOYD JOE WILLIAM·Filed 2011·Application pending·0 cites
- 3630US6472418B1Non-peptide NK1 receptors antagonistsWARNER LAMBERT CO·Filed 1999·Granted Oct 29, 2002·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Michael Higginbottom files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →